The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization
暂无分享,去创建一个
F. Fedele | C. Lavalle | M. Mancone | G. Sardella | F. Infusino | S. Calcagno | P. Severino | M. Pucci | L. Birtolo | N. Salvi | R. Colantonio | Temistocle Taccheri | E. Bruno | Mariateresa Pucci | Simone Calcagno
[1] Marco Valgimigli,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.
[2] Jinyu Huang,et al. Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: a Meta-analysis of Randomized Controlled Trials. , 2019, Clinical therapeutics.
[3] U. Baber,et al. Safety and Efficacy of Polymer-Free Drug-Eluting Stents: Amphilimus-Eluting Cre8 Versus Biolimus-Eluting BioFreedom Stents , 2019, Circulation. Cardiovascular interventions.
[4] F. Fedele,et al. Effects of Ivabradine on Residual Myocardial Ischemia after PCI Evaluated by Stress Echocardiography , 2019, Cardiology research and practice.
[5] Mahraz Parvand,et al. Ranolazine for Symptomatic Management of Microvascular Angina. , 2020, American journal of therapeutics.
[6] C. Briguori,et al. Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[7] P. Stella,et al. Clinical outcomes with reservoir‐based polymer‐free amphilimus‐eluting stents in real‐world patients according to diabetes mellitus and complexity: The INVESTIG8 registry , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[8] G. Niccoli,et al. Angina after percutaneous coronary intervention: The need for precision medicine. , 2017, International journal of cardiology.
[9] M. Mancone,et al. Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus. , 2017, Circulation.
[10] Mark W. Sheldon,et al. Impact of ranolazine on coronary microvascular dysfunction (MICRO) study. , 2017, Cardiovascular revascularization medicine : including molecular interventions.
[11] G. Signoriello,et al. Coronary artery bifurcation narrowing treated by Axxess stent implantation: The CARINAX registry , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[12] A. Sinusas,et al. Ranolazine and Microvascular Angina by PET in the Emergency Department: Results From a Pilot Randomized Controlled Trial. , 2017, Clinical therapeutics.
[13] A. Pichard,et al. Frequency of Angina Pectoris After Percutaneous Coronary Intervention and the Effect of Metallic Stent Type. , 2016, The American journal of cardiology.
[14] K. Alexander,et al. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial , 2016, The Lancet.
[15] K. Anstrom,et al. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial , 2016, Circulation.
[16] I. Savelieva,et al. Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis , 2015, European journal of preventive cardiology.
[17] A. Gallino,et al. Ranolazine: Drug overview and possible role in primary microvascular angina management. , 2015, International journal of cardiology.
[18] V. Figueredo,et al. Update on ranolazine in the management of angina , 2014, Vascular health and risk management.
[19] G. Rosano,et al. Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis. , 2013, International journal of cardiology.
[20] Jeroen J. Bax,et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.
[21] M. Mancone,et al. Do angle and anatomy influence outcomes in bifurcation stenting? , 2013, Minerva cardioangiologica.
[22] B. Chaitman,et al. Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials. , 2007, The American journal of cardiology.
[23] M. Jetté,et al. Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity , 1990, Clinical cardiology.